1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Gastrointestinal
OTC Drugs Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By Drug Class (Laxatives, Gastrointestinal Cancer
Treatments, Gastric Acid Reducers, Anti-Diarrheal, Proton Pump Inhibitors, H2
Inhibitors, Gastric Acid Neutralizers, Bowel Anti-Inflammatory, Anti-Emetics)
5.2.2.
By Indication (Gastroesophageal Reflux Disease or
Heartburn, Constipation, Diarrhea, Motion Sickness, and Others)
5.2.3.
By End User (Hospitals Pharmacies, Retail Pharmacies,
Online pharmacies, others)
5.2.4.
By Region
5.2.5.
By Company (2022)
5.3.
Market Map
6. Asia Pacific Gastrointestinal
OTC Drugs Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By
Drug Class
6.2.2.
By Indication
6.2.3.
By End
User
6.2.4.
By Country
6.3.
Asia Pacific: Country Analysis
6.3.1.
China Gastrointestinal OTC Drugs Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Drug
Class
6.3.1.2.2.
By
Indication
6.3.1.2.3.
By End
User
6.3.2.
India Gastrointestinal OTC Drugs Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Drug
Class
6.3.2.2.2.
By
Indication
6.3.2.2.3.
By End
User
6.3.3.
Australia Gastrointestinal OTC Drugs Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Drug
Class
6.3.3.2.2.
By
Indication
6.3.3.2.3.
By End
User
6.3.4.
Japan Gastrointestinal OTC Drugs Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Drug
Class
6.3.4.2.2.
By
Indication
6.3.4.2.3.
By End
User
6.3.5.
South Korea Gastrointestinal OTC Drugs Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Drug
Class
6.3.5.2.2.
By
Indication
6.3.5.2.3.
By End
User
7. Europe Gastrointestinal
OTC Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Drug
Class
7.2.2.
By
Indication
7.2.3.
By End
User
7.2.4.
By
Country
7.3.
Europe: Country Analysis
7.3.1.
France Gastrointestinal OTC Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug
Class
7.3.1.2.2.
By
Indication
7.3.1.2.3.
By End
User
7.3.2.
Germany Gastrointestinal OTC Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Class
7.3.2.2.2.
By
Indication
7.3.2.2.3.
By End
User
7.3.3.
Spain Gastrointestinal OTC Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug
Class
7.3.3.2.2.
By
Indication
7.3.3.2.3.
By End
User
7.3.4.
Italy Gastrointestinal OTC Drugs Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug
Class
7.3.4.2.2.
By
Indication
7.3.4.2.3.
By End
User
7.3.5.
United Kingdom Gastrointestinal OTC Drugs Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug
Class
7.3.5.2.2.
By
Indication
7.3.5.2.3.
By End
User
8. North America Gastrointestinal
OTC Drugs Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Drug
Class
8.2.2.
By
Indication
8.2.3.
By End
User
8.2.4.
By Country
8.3.
North America: Country Analysis
8.3.1.
United States Gastrointestinal OTC Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug
Class
8.3.1.2.2.
By
Indication
8.3.1.2.3.
By End
User
8.3.2.
Mexico Gastrointestinal OTC Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug
Class
8.3.2.2.2.
By
Indication
8.3.2.2.3.
By End
User
8.3.3.
Canada Gastrointestinal OTC Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug
Class
8.3.3.2.2.
By
Indication
8.3.3.2.3.
By End
User
9. South America Gastrointestinal
OTC Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Drug
Class
9.2.2.
By
Indication
9.2.3.
By End
User
9.2.4.
By Country
9.3.
South America: Country Analysis
9.3.1.
Brazil Gastrointestinal OTC Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug
Class
9.3.1.2.2.
By
Indication
9.3.1.2.3.
By End
User
9.3.2.
Argentina Gastrointestinal OTC Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug
Class
9.3.2.2.2.
By
Indication
9.3.2.2.3.
By End
User
9.3.3.
Colombia Gastrointestinal OTC Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug
Class
9.3.3.2.2.
By
Indication
9.3.3.2.3.
By End
User
10. Middle East and Africa
Gastrointestinal OTC Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Indication
10.2.3. By End User
10.2.4. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Gastrointestinal
OTC Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Drug
Class
10.3.1.2.2.
By
Indication
10.3.1.2.3.
By End
User
10.3.2. Saudi Arabia Gastrointestinal
OTC Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Drug
Class
10.3.2.2.2.
By
Indication
10.3.2.2.3.
By End
User
10.3.3. UAE Gastrointestinal
OTC Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Drug
Class
10.3.3.2.2.
By
Indication
10.3.3.2.3.
By End
User
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers & Acquisitions
13.
Global Gastrointestinal OTC Drugs Market: SWOT Analysis
14. Porter’s Five Forces
Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Product
15.
PESTLE Analysis
16.
Competitive Landscape
16.1. Mylan N.V.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products &
Services
16.1.4. Financials (In case
of listed companies)
16.1.5. Recent Developments
16.1.6. SWOT Analysis
16.2. Sandoz AG
16.2.1. Business Overview
16.2.2. Company Snapshot
16.2.3. Products &
Services
16.2.4. Financials (In case
of listed companies)
16.2.5. Recent Developments
16.2.6. SWOT Analysis
16.3. Johnson &
Johnson Services, Inc.
16.3.1. Business Overview
16.3.2. Company Snapshot
16.3.3. Products &
Services
16.3.4. Financials (In case
of listed companies)
16.3.5. Recent Developments
16.3.6. SWOT Analysis
16.4. Sun Pharmaceuticals
Industries Limited
16.4.1. Business Overview
16.4.2. Company Snapshot
16.4.3. Products &
Services
16.4.4. Financials (In case
of listed companies)
16.4.5. Recent Developments
16.4.6. SWOT Analysis
16.5. Teva Pharmaceuticals
Industries Ltd
16.5.1. Business Overview
16.5.2. Company Snapshot
16.5.3. Products &
Services
16.5.4. Financials (In case
of listed companies)
16.5.5. Recent Developments
16.5.6. SWOT Analysis
16.6. Zydus Lifesciences
Ltd.
16.6.1. Business Overview
16.6.2. Company Snapshot
16.6.3. Products &
Services
16.6.4. Financials (In case
of listed companies)
16.6.5. Recent Developments
16.6.6. SWOT Analysis
16.7. Sanofi SA
16.7.1. Business Overview
16.7.2. Company Snapshot
16.7.3. Products &
Services
16.7.4. Financials (In case
of listed companies)
16.7.5. Recent Developments
16.7.6. SWOT Analysis
16.8. Bayer AG
16.8.1. Business Overview
16.8.2. Company Snapshot
16.8.3. Products &
Services
16.8.4. Financials (In case
of listed companies)
16.8.5. Recent Developments
16.8.6. SWOT Analysis
16.9. Pfizer Inc.
16.9.1. Business Overview
16.9.2. Company Snapshot
16.9.3. Products &
Services
16.9.4. Financials (In case
of listed companies)
16.9.5. Recent Developments
16.9.6. SWOT Analysis
16.10.GlaxoSmithKline Plc.
16.10.1. Business Overview
16.10.2. Company Snapshot
16.10.3. Products & Services
16.10.4. Financials (In case
of listed companies)
16.10.5. Recent Developments
16.10.6. SWOT Analysis
17. Strategic Recommendations
About Us & Disclaimer